Clene Inc. (CLNN)vsJBS N.V. (JBS)
CLNN
Clene Inc.
$3.57
-2.19%
CONSUMER DEFENSIVE · Cap: $45.87M
JBS
JBS N.V.
$12.59
-0.20%
CONSUMER DEFENSIVE · Cap: $14.50B
Smart Verdict
WallStSmart Research — data-driven comparison
JBS N.V. generates 46278180% more annual revenue ($91.17B vs $197,000). JBS leads profitability with a 1.2% profit margin vs 0.0%. JBS earns a higher WallStSmart Score of 39/100 (F).
CLNN
Avoid34
out of 100
Grade: F
JBS
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-62.6%
Fair Value
$2.54
Current Price
$3.57
$1.03 premium
Intrinsic value data unavailable for JBS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 233.3% year-over-year
Earnings expanding 61.4% YoY
Conservative balance sheet, low leverage
Every $100 of equity generates 78 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
ROE of -1738.0% — below average capital efficiency
1.2% margin — thin
Operating margin of 3.1%
Earnings declined 57.2%
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : CLNN
The strongest argument for CLNN centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 233.3% demonstrates continued momentum.
Bull Case : JBS
The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.
Bear Case : CLNN
The primary concerns for CLNN are Market Cap, Profit Margin, Piotroski F-Score.
Bear Case : JBS
The primary concerns for JBS are Profit Margin, Operating Margin, EPS Growth. Debt-to-equity of 2.97 is elevated, increasing financial risk. Thin 1.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
CLNN profiles as a hypergrowth stock while JBS is a value play — different risk/reward profiles.
CLNN is growing revenue faster at 233.3% — sustainability is the question.
JBS generates stronger free cash flow (240M), providing more financial flexibility.
Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
JBS scores higher overall (39/100 vs 34/100) and 13.8% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Clene Inc.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
JBS N.V.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.
Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?